Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.86 -0.08 (-8.41%)
As of: Sep 30, 2026 · 3:59 PM EDT

Bluejay Diagnostics (BJDX) Receivables - Other (2022 - 2025)

Updated

Bluejay Diagnostics (BJDX) recorded Receivables - Other of $6,873 in Q1 2025, down 90.7% from $73,591 a year earlier and down 52.8% from the prior quarter.

Analysis

Bluejay Diagnostics (BJDX) Receivables - Other (2022 - 2025) Analysis & Trends

At the end of FY2024, Bluejay Diagnostics reported Receivables - Other of $14,564, down 64.7% from FY2023.

  • Across earlier years, Receivables - Other came in at $41,269 in FY2023 (+109.2%) and $19,731 in FY2022.
  • Per Business Quant, the preceding three quarters came in at $14,564 (Q4 2024), $8,315 (Q3 2024) and $30,609 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 Bluejay Diagnostics 1.86 Mn 1.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 6,873.00
Dec 31, 2024 14,564.00
Sep 30, 2024 8,315.00
Jun 30, 2024 30,609.00
Mar 31, 2024 73,591.00
Dec 31, 2023 41,269.00
Dec 31, 2022 19,731.00
API Access

Bluejay Diagnostics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=BJDX&period=max&api_key=YOUR_API_KEY